Pony Testing Co., Ltd. operates as a testing, inspecting, and certification company in China. The company offers biopharmaceutical CRO/CDMO and drug testing services; medical device testing; medical testing/pathological diagnosis; toxicology and pathology experiments; food/liquor/beverage testing; agricultural product testing; and health product testing services. It also provides drinking water/mineral water and other packaged water products testing; ecological environment monitoring; environmental consulting and operation/environmental stewardship/identification of hazardous waste properties; and energy saving and carbon reduction/carbon measurement/carbon footprint/carbon neutralization/ESG services. In addition, the company offers occupational health/public health/school health; nuclear and radiation/radiation health; automobile whole vehicle/parts/new energy vehicle testing; new energy vehicle power battery and energy storage battery detection; electronic and electrical testing/electrical equipment testing; evaluation of transport conditions of dangerous goods; e-cigarette testing and certification; cosmetics testing; and human efficacy test of cosmetics services. Further, it provides consumer goods/textiles/toys/oil products testing ink coating/chemical product testing; special equipment inspection and testing; inspection of goods/factory; certification service/two-party audit; disinfection and sterilization; nondestructive testing; environmental reliability test; EMC testing for military and civil electromagnetic compatibility; training services; military and civil software evaluation/network security; quick test; and e-commerce testing services. The company was founded in 2002 and is headquartered in Beijing, China.
Metrics to compare | 300887 | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship Relationship300887PeersSector | |
---|---|---|---|---|
P/E Ratio | −13.3x | −19.9x | 12.7x | |
PEG Ratio | 0.00 | 0.01 | 0.03 | |
Price/Book | 1.7x | 3.8x | 1.4x | |
Price / LTM Sales | 3.4x | 5.1x | 1.3x | |
Upside (Analyst Target) | −44.5% | −31.5% | 14.3% | |
Fair Value Upside | Unlock | −27.3% | 5.3% | Unlock |